The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation (Q42542905)

2 November 2017

title

The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation (English)

1 reference

2 November 2017

P A Belinky

1 reference

2 November 2017

M Aviram

1 reference

2 November 2017

B Fuhrman

1 reference

2 November 2017

M Rosenblat

1 reference

2 November 2017

J Vaya

1 reference

2 November 2017

publication date

1 March 1998

1 reference

2 November 2017

1 reference

2 November 2017

volume

137

1 reference

2 November 2017

1 reference

2 November 2017

page(s)

49-61

1 reference

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Another cholesterol hypothesis: cholesterol as antioxidant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Continuous monitoring of in vitro oxidation of human low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Biochemical, structural, and functional properties of oxidized low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Alpha-tocopherol consumption during low-density-lipoprotein oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

The action of defined oxygen-centred free radicals on human low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Probucol inhibits oxidative modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Glycyrrhiza glabra extract as an effector of interception in Escherichia coli K12+

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Reduced Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice Following Consumption of Red Wine, or Its Polyphenols Quercetin or Catechin, Is Associated With Reduced Susceptibility of LDL to Oxidation and Aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Microsomal lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Antioxidant Determinations by the Use of a Stable Free Radical

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Biological effects of oxysterols: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Copper-induced lipid peroxidation in liposomes, micelles, and LDL: which is the role of vitamin E?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Biological activities of oxysterols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Toxicity of oxysterols to human monocyte-macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Hydroxypropyl-beta-cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Lipids and oxidised lipids in human atheroma and normal aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Oxidation of cholesteryl linoleate by human monocyte-macrophages in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Oxidation of cholesterol moiety of low density lipoprotein in the presence of human endothelial cells or Cu+2 ions: identification of major products and their effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Capillary gas chromatography quantification of cholesterol in copper-oxidized low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Evidence for the presence of 7-hydroperoxycholest-5-en-3 beta-ol in oxidized human LDL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Contribution of vitamin A to the oxidation resistance of human low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

The effect of fatty acid unsaturation on the antioxidant activity of beta-carotene and alpha-tocopherol in hexane solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Varying susceptibility of different low density lipoproteins to oxidative modification.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900251-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(97)00251-7

1 reference

2 November 2017

1 reference